Skip to main content
Fig. 1 | Clinical Epigenetics

Fig. 1

From: Chidamide, decitabine, cytarabine, aclarubicin, and granulocyte colony-stimulating factor (CDCAG) in patients with relapsed/refractory acute myeloid leukemia: a single-arm, phase 1/2 study

Fig. 1

Survival curves. a Overall survival curves for 93 patients with r/r AML. b Relapse-free survival curves for 43 patients with r/r AML. c Overall survival curves for 93 patients with r/r AML. Data are categorized according to whether CR/CRi was achieved. r/r AML, relapse/refractory acute myeloid leukemia; CR/CRi, complete remission or complete remission with incomplete count recovery

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us